Logo image of OBIO

ORCHESTRA BIOMED HOLDINGS IN (OBIO) Stock Earnings & Estimates

USA - NASDAQ:OBIO - US68572M1062 - Common Stock

4.34 USD
-0.32 (-6.87%)
Last: 11/20/2025, 2:18:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
OBIO revenue by date.OBIO revenue by date.
3.53M
552.56%
2.76M
-21.81%
2.638M
-4.42%
3.467M
31.43%
3.844M
10.87%
2.805M
-27.03%
23.528M
738.79%
65.497M
178.38%
124.45M
90.01%
134.95M
8.44%
175.85M
30.31%
EBITDA
YoY % growth
OBIO ebitda by date.OBIO ebitda by date.
-32.44M
-50.05%
-51.219M
-57.89%
-63.993M
-24.94%
-79.662M
-24.49%
-86.292M
-8.32%
-88.332M
-2.36%
-80.886M
8.43%
-57.834M
28.50%
-23.358M
59.61%
10.914M
146.72%
52.734M
383.18%
EBIT
YoY % growth
OBIO ebit by date.OBIO ebit by date.
-32.66M
-49.82%
-51.506M
-57.70%
-64.301M
-24.84%
-80.127M
-24.61%
-85.078M
-6.18%
-80.486M
5.40%
-58.127M
27.78%
-20.254M
65.16%
26.441M
230.55%
10.098M
-61.81%
51.714M
412.12%
Operating Margin
OBIO operating margin by date.OBIO operating margin by date.
-925.21%-1,866.16%-2,437.49%-2,311.14%-2,213.28%-2,869.38%-247.05%-30.92%21.25%7.48%29.41%
EPS
YoY % growth
OBIO eps by date.OBIO eps by date.
N/A-1.50
84.66%
-1.66
-10.67%
-1.80
-8.67%
-1.52
15.79%
-1.13
25.47%
-0.63
44.14%
-0.04
94.35%
0.57
1,700.00%
0.05
-91.07%
0.27
420.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.41
3.24%
-0.42
15.07%
-0.40
19.62%
-0.39
2.59%
-0.41
-0.54%
Revenue
Q2Q % growth
892.092K
252.61%
867.204K
-0.09%
879.036K
5.15%
874.548K
1.57%
909.585K
1.96%
EBITDA
Q2Q % growth
-19.329M
-18.08%
-22.848M
-21.29%
-21.318M
-11.25%
-21.114M
-5.21%
-22.236M
-15.04%
EBIT
Q2Q % growth
-20.871M
-25.15%
-22.24M
-17.54%
-21.444M
-10.95%
-21.097M
-3.86%
-20.549M
1.54%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.40
2.44%
-0.440.049.82%
Q2 2025
Q2Q % growth
-0.50
-11.11%
-0.510.012.68%
Q1 2025
Q2Q % growth
-0.49
-28.95%
-0.490.000.13%
Q4 2024
Q2Q % growth
-0.42
-13.51%
-0.440.023.57%
Q3 2024
Q2Q % growth
-0.41
-7.89%
-0.440.036.52%
Q2 2024
Q2Q % growth
-0.45
-28.57%
-0.40-0.05-12.33%
Q1 2024
Q2Q % growth
-0.38
5.00%
-0.410.036.39%
Q4 2023
Q2Q % growth
-0.37
78.79%
-0.380.013.65%
Q3 2023
Q2Q % growth
-0.38 -0.400.024.47%
Q2 2023
Q2Q % growth
-0.35 -0.420.0717.32%
Q1 2023
Q2Q % growth
-0.40 -0.29-0.11-37.60%
OBIO Yearly EPS VS EstimatesOBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
861K
-12.77%
772.752K88.248K11.42%
Q2 2025
Q2Q % growth
836K
7.46%
709.512K126.488K17.83%
Q1 2025
Q2Q % growth
868K
40.00%
537.03K330.97K61.63%
Q4 2024
Q2Q % growth
253K
-3.44%
857.993K-604.993K-70.51%
Q3 2024
Q2Q % growth
987K
135.56%
725.73K261.27K36.00%
Q2 2024
Q2Q % growth
778K
-14.97%
870.57K-92.57K-10.63%
Q1 2024
Q2Q % growth
620K
-46.74%
955.403K-335.403K-35.11%
Q4 2023
Q2Q % growth
262K
-76.18%
1.014M-752K-74.16%
Q3 2023
Q2Q % growth
419K
-63.88%
912.9K-493.9K-54.10%
Q2 2023
Q2Q % growth
915K
128.75%
720.12K194.88K27.06%
Q1 2023
Q2Q % growth
1.164M
33.79%
693.6K470.4K67.82%
Q4 2022
Q2Q % growth
1.1M
144.90%
1.204M-104K-8.64%
Q3 2022
Q2Q % growth
1.16M
-12.78%
%
Q2 2022
Q2Q % growth
400K
140.82%
%
Q1 2022
Q2Q % growth
870K
-34.09%
%
OBIO Yearly Revenue VS EstimatesOBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS5.29% 13.37% 3.72% 11.43%
Revenue3.1% 16.41% 1.67% 9.09%